Facing Purdue Owners Brings Pain, Closure for Opioid Victims March 14, 2022 By Jennifer Peltz and Geoff Mulvihill NEW YORK (AP) — Kara Trainor composed herself, looked into a camera and began to speak to the drugmakers she...
Opioid Victims to Confront Purdue Pharma’s Sacklers in Court March 10, 2022 By Tom Hals and Dietrich Knauth Victims of America’s opioid addiction epidemic will confront in court on Thursday the Sackler family members who own OxyContin-maker Purdue...
Purdue Pharma Judge Overrules DOJ to Approve $6B Opioid Settlement March 10, 2022 By Dietrich Knauth and Tom Hals The judge overseeing Purdue Pharma’s bankruptcy on Wednesday approved a $6 billion opioid settlement funded by its Sackler family owners,...
Delaware Supreme: Insurers Have No Duty to Defend Rite Aid Against Opioid Lawsuits January 11, 2022 By Claims Journal staff Chubb Ltd. has no duty to defend Rite Aid Corp. against lawsuits filed by two Ohio counties that allege the...
All But a Few States Now Accept Purdue Pharma, Sackler Family Deal July 9, 2021 By Mike Spector Fifteen more states reached an agreement with Purdue Pharma LP and members of its wealthy Sackler family owners that moved...
Key States Agree to Revised Deal with Purdue Pharma, Sacklers July 8, 2021 By Erik Larson and Jeremy Hill Purdue Pharma LP won the support of more than a dozen states that had opposed its $4.5 billion bankruptcy plan...
Purdue Pharma to Use Public Trusts, Sackler Cash to Settle Opioid Litigation March 16, 2021 By Maria Chutchian and Mike Spector Purdue Pharma LP filed a bankruptcy plan on Monday that would resolve thousands of opioid lawsuits by restructuring the OxyContin...
Sacklers Withdrew $10 Billion Out of Purdue, Report Finds December 17, 2019 By Jef Feeley and Erik Larson Opponents of the Sackler family’s offer to settle opioid lawsuits against Purdue Pharma LP for about $10 billion say a...
Purdue Judge Halts Government Opioid Suits Against Drugmaker October 14, 2019 By Steven Church and Erik Larson Purdue Pharma LP and its billionaire owners won a temporary reprieve from nearly 2,700 opioid lawsuits, giving the bankrupt drugmaker...
Teva’s Budding Blockbuster Drugs Lend Respite From Legal Concerns August 7, 2019 By Ilya Khrennikov Teva Pharmaceutical Industries Ltd. is preparing for a potential reckoning with the U.S. epidemic of opioid addiction. The drugmaker’s shares...